Further studies identified that TPL significantly reduced Nrf2 expression and transcriptional activity in NSCLC and liver cancer cells, which resulted in chemosensitivity to antitumor drugs in vitro and in a xenograft tumor model system using lung carcinoma cells 104. The gene discussed is NFE2L2; the disease is lung carcinoma.